Mario Cazzola

77.2k total citations · 7 hit papers
428 papers, 25.3k citations indexed

About

Mario Cazzola is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Mario Cazzola has authored 428 papers receiving a total of 25.3k indexed citations (citations by other indexed papers that have themselves been cited), including 291 papers in Hematology, 237 papers in Genetics and 109 papers in Molecular Biology. Recurrent topics in Mario Cazzola's work include Acute Myeloid Leukemia Research (158 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (139 papers) and Hemoglobinopathies and Related Disorders (74 papers). Mario Cazzola is often cited by papers focused on Acute Myeloid Leukemia Research (158 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (139 papers) and Hemoglobinopathies and Related Disorders (74 papers). Mario Cazzola collaborates with scholars based in Italy, United States and United Kingdom. Mario Cazzola's co-authors include Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Clara D. Bloomfield, Michael J. Borowitz, Jürgen Thiele, James W. Vardiman, Michelle M. Le Beau, Francesco Passamonti and Luca Malcovati and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Mario Cazzola

413 papers receiving 24.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2016 6.0k citations Daniel A. Arber, Attilio Orazi et al. Blood profile →
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

2005 2.6k citations Róbert Královics, Francesco Passamonti et al. profile →
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

2007 695 citations Luca Malcovati, Ulrich Germing et al. profile →
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

2009 623 citations Francesco Passamonti, Francisco Cervantes et al. Blood profile →
Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

2005 618 citations Luca Malcovati, Cristiana Pascutto et al. profile →
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

2013 391 citations Elisa Rumi, Daniela Pietra et al. Blood profile →
Myelodysplastic Syndromes

2020 272 citations Mario Cazzola profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mario Cazzola Italy	73	17.6k	15.1k	9.2k	4.4k	2.3k	428	25.3k
Srđan Verstovšek United States	84	18.6k 1.1×	18.7k 1.2×	12.1k 1.3×	8.5k 1.9×	4.4k 1.9×	1.1k	30.0k
Giuseppe Saglio Italy	75	18.5k 1.0×	13.4k 0.9×	5.6k 0.6×	7.0k 1.6×	4.3k 1.9×	650	25.0k
Zeev Estrov United States	82	13.3k 0.8×	10.5k 0.7×	11.7k 1.3×	2.4k 0.5×	4.8k 2.1×	669	26.3k
John M. Goldman United Kingdom	83	22.2k 1.3×	14.3k 0.9×	5.1k 0.6×	8.6k 2.0×	5.1k 2.2×	496	29.8k
Alessandro Rambaldi Italy	83	9.6k 0.5×	8.5k 0.6×	8.1k 0.9×	2.8k 0.6×	5.6k 2.4×	661	24.3k
Michele Baccarani Italy	80	20.3k 1.2×	14.6k 1.0×	4.9k 0.5×	8.1k 1.9×	5.9k 2.6×	711	29.1k
Pierre Fenaux France	90	27.8k 1.6×	11.4k 0.7×	15.7k 1.7×	1.6k 0.4×	5.3k 2.3×	869	36.8k
Deborah A. Thomas United States	80	12.3k 0.7×	10.2k 0.7×	6.3k 0.7×	2.6k 0.6×	4.9k 2.1×	451	23.2k
Oliver G. Ottmann Germany	62	10.4k 0.6×	5.0k 0.3×	4.9k 0.5×	2.8k 0.6×	4.0k 1.7×	372	16.1k
Stefan Faderl United States	88	17.0k 1.0×	10.9k 0.7×	8.2k 0.9×	3.5k 0.8×	5.3k 2.3×	570	27.0k

Countries citing papers authored by Mario Cazzola

Since Specialization

Citations

This map shows the geographic impact of Mario Cazzola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Cazzola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Cazzola more than expected).

Fields of papers citing papers by Mario Cazzola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Cazzola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Cazzola. The network helps show where Mario Cazzola may publish in the future.

Co-authorship network of co-authors of Mario Cazzola

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Cazzola. A scholar is included among the top collaborators of Mario Cazzola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Cazzola. Mario Cazzola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cazzola, Mario, Paola Rogliani, Luigino Calzetta, & Maria Gabriella Matera. (2023). Tozorakimab. Anti-IL-33 monoclonal antibody, Treatment of COPD and asthma, Treatment of atopic dermatitis, Treatment of diabetic kidney disease. Drugs of the Future. 48(2). 101–109. 4 indexed citations

Cazzola, Mario. (2023). Introduction to a review series on myelodysplastic syndromes in the age of genomic medicine. Blood. 142(26). 2223–2223. 1 indexed citations

Molteni, Elisabetta, Elisa Bono, Anna Gallì, et al.. (2023). Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity. Blood. 142(7). 643–657. 9 indexed citations

Guzzi, Nicola, Sowndarya Muthukumar, Maciej Cieśla, et al.. (2022). Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nature Cell Biology. 24(3). 299–306. 78 indexed citations

Kotini, Andriana G., Elsa Bernard, Davide Esposito, et al.. (2022). Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs. Blood Advances. 6(10). 2992–3005. 8 indexed citations

Bridgford, Jessica L., Su Min Lee, Paola Guglielmelli, et al.. (2019). Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning. Blood. 135(4). 287–292. 34 indexed citations

Bono, Elisa, Donal P. McLornan, Erica Travaglino, et al.. (2017). Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization. Blood. 130. 588–588. 1 indexed citations

Arber, Daniel A., Attilio Orazi, Robert P. Hasserjian, et al.. (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127(20). 2391–2405. 6033 indexed citations breakdown →

Tefferi, Ayalew, Francesco Passamonti, Tiziano Barbui, et al.. (2013). Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence. Blood. 122(21). 394–394. 24 indexed citations

10.

Rumi, Elisa, Daniela Pietra, Virginia Valeria Ferretti, et al.. (2013). JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 123(10). 1544–1551. 391 indexed citations breakdown →

11.

Nikpour, Maryam, Andrea Pellagatti, Luca Malcovati, et al.. (2009). NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING. Oxford University Research Archive (ORA) (University of Oxford). 94. 99–99. 1 indexed citations

12.

Cazzola, Mario, Sanjay Sethi, Francesco Blasi, & Antonio Anzueto. (2009). Therapeutic strategies in acute exacerbations in COPD. 1 indexed citations

13.

Mufti, G J, John M. Bennett, J Goasguen, et al.. (2008). Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 93(11). 1712–1717. 180 indexed citations

14.

Cazzola, Mario. (2005). Pyruvate kinase deficiency.. PubMed. 90(1). 1–2. 3 indexed citations

15.

Alessandrino, Emilio Paolo, Sergio Amadori, Giovanni Barosi, et al.. (2002). Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.. PubMed. 87(12). 1286–306. 141 indexed citations

16.

Polverino, Mario, et al.. (1997). Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease. European Respiratory Journal. 10(1). 98–103. 18 indexed citations

17.

Cazzola, Mario, et al.. (1989). Therapeutic implications of treatment with cefonicid on airway reactivity during bacterial lower respiratory tract infections. Current Therapeutic Research. 45(4). 559–567. 1 indexed citations

18.

Ucci, G., et al.. (1985). Proliferation kinetics of bone marrow cells in congenital dyserythropoietic anemia type II. Annals of Hematology. 50(4). 219–224. 2 indexed citations

19.

Cazzola, Mario, Giovanni Barosi, Ester Orlandi, & Mario Stefanelli. (1979). The plasma59Fe clearance curve in man. Annals of Hematology. 40(5). 325–335. 8 indexed citations

20.

Barosi, Giovanni, S Morandi, Mario Cazzola, Giovanni Ricevuti, & E Ascari. (1978). Abnormal splenic uptake of red cells in long-lasting iron deficiency anemia due to self-induced bleeding (factitious anemia). Annals of Hematology. 37(2). 75–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact